logo

Mucosal Environment and HIV Prevention (MEHP II) (R01)

Sector: Hospital • Location: United States of America

Source: Grants.gov

Project
Archived

The purpose of the Mucosal Environment and HIV Prevention II (MEHP II) Funding Opportunity Announcement (FOA) is to solicit applications that support innovative proof-of-concept/feasibility non-vaccine biomedical prevention (nBP) research needed to support and advance the development of safer and more effective microbicides and Pre-Exposure Prophylaxis (PrEP) strategies. The MEHP II will support i

Project Information FAQ

Project Information

5 Q
The project “Mucosal Environment and HIV Prevention (MEHP II) (R01)” is an infrastructure initiative in the Hospital sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

archived

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

The purpose of the Mucosal Environment and HIV Prevention II (MEHP II) Funding Opportunity Announcement (FOA) is to solicit applications that support innovative proof-of-concept/feasibility non-vaccine biomedical prevention (nBP) research needed to support and advance the development of safer and more effective microbicides and Pre-Exposure Prophylaxis (PrEP) strategies. The MEHP II will support innovative, high-risk, hypothesis-driven research that provides a better understanding of how prevention products/drug delivery strategies interact with the micro- and macro-environments of the male and female genital and gastrointestinal (GI) mucosa. This FOA is intended to support innovative biomedical research efforts, which may or may not involve active pharmaceutical ingredients (APIs), formulation/excipient and/or a device currently under development. This FOA is not intended to support the preclinical or clinical development of new nBP candidates or their delivery systems.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data